



Cannabis research becomes a priority at UFSM following Anvisa regulation authorizing cultivation for scientific purposes in Brazil. Check it out!
Company invests in clinical studies, rigorous quality control, and transparency to stand out in the global CBD market
Biological understanding, clinical applications, and public policies show why the plant should be treated as a therapeutic resource — not just as a recreational or harmful substance
Phase 3 clinical trial published in Nature Medicine evaluated standardized cannabis extract in patients with chronic low back pain, showing improvement in symptoms, sleep, and physical function
How the pharmaceutical industry ensures quality and safety in cannabis-based products sold in Brazil